Clinical Trial Update: Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating decreased usage of beta-blockers after myocardial infarction in the SWEDEHEART registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• beta-blockers (beta-adrenergic blocker)

Snippet

Sponsor: Karolinska Institutet | Conditions: Acute Myocardial Infarction, Non-ST Elevation Myocardial Infarction | Phase 4 | Status: UNKNOWN